Wordt geladen...
Update on corticosteroids for diabetic macular edema
Diabetic macular edema (DME) remains an important cause of visual loss. Although anti-vascular endothelial growth factor (VEGF) agents are generally used as first-line treatments for patients with center-involving DME, there is an important role for corticosteroids as well. Corticosteroids may be es...
Bewaard in:
| Gepubliceerd in: | Clin Ophthalmol |
|---|---|
| Hoofdauteurs: | , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Dove Medical Press
2016
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5019446/ https://ncbi.nlm.nih.gov/pubmed/27660409 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OPTH.S115546 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|